Science 37 Hldgs Inc (SNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 06-2021 | 12-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,988 | -94,331 | -561 | N/A | -1 |
| Depreciation Amortization | 17,942 | 7,799 | N/A | 0 | N/A |
| Accounts receivable | -821 | 232 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -6,778 | 5,243 | N/A | N/A | N/A |
| Other Working Capital | -13,367 | 7,397 | 10 | -129 | 1 |
| Other Operating Activity | -21,431 | 37,182 | -30 | -86 | 0 |
| Operating Cash Flow | $-75,443 | $-36,478 | $-582 | $-215 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,874 | -20,576 | N/A | 0 | N/A |
| Purchase Of Investment | N/A | N/A | -80,090 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -80,090 | 0 |
| Investing Cash Flow | $-31,874 | $-20,576 | $-80,090 | $-80,090 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 175 | N/A | N/A |
| Debt Repayment | N/A | N/A | -175 | N/A | N/A |
| Common Stock Issued | 610 | 185,972 | 81,320 | N/A | 25 |
| Other Financing Activity | 0 | 52,200 | -257 | 81,063 | 0 |
| Financing Cash Flow | $610 | $238,172 | $81,064 | $81,063 | $25 |
| Exchange Rate Effect | 197 | N/A | N/A | 0 | N/A |
| Beginning Cash Position | 214,601 | 33,483 | 25 | 25 | N/A |
| End Cash Position | 108,091 | 214,601 | 416 | N/A | 25 |
| Net Cash Flow | $-106,510 | $181,118 | $391 | $758 | $25 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,443 | -36,478 | -582 | -215 | N/A |
| Capital Expenditure | -31,874 | -20,576 | N/A | N/A | N/A |
| Free Cash Flow | -107,317 | -57,054 | -582 | -215 | 0 |